- Home
- FHTX vs KINS Comparison
FHTX vs KINS Comparison
Compare FHTX & KINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FHTX | KINS |
|---|---|---|
| Founded | 2015 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.6M | 284.5M |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | FHTX | KINS |
|---|---|---|
| Price | $4.20 | $19.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | ★ 382.8K | 60.6K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.18% |
| EPS Growth | 25.32 | ★ 94.59 |
| EPS | N/A | ★ 0.66 |
| Revenue | $30,909,000.00 | ★ $214,867,301.00 |
| Revenue This Year | $8.89 | $24.23 |
| Revenue Next Year | $20.13 | $18.05 |
| P/E Ratio | ★ N/A | $29.67 |
| Revenue Growth | 36.75 | ★ 38.50 |
| 52 Week Low | $3.27 | $13.38 |
| 52 Week High | $7.61 | $20.90 |
Technical Indicators
Market Signals| Indicator | FHTX | KINS |
|---|---|---|
| Relative Strength Index (RSI) | 25.10 | 48.63 |
| Support Level | $3.57 | $18.68 |
| Resistance Level | $5.35 | $20.62 |
| Average True Range (ATR) | 0.33 | 0.44 |
| MACD | -0.20 | -0.05 |
| Stochastic Oscillator | 2.57 | 40.88 |
Price Performance
Historical ComparisonAbout FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
About KINS Kingstone Companies Inc.
Kingstone Companies Inc offers property and casualty insurance products through its subsidiary engaged in writing business through retail and wholesale agents and brokers. Its products include Personal lines, Livery physical damage, and Others. It operates in single segment, property and casualty insurance. It derives substantially all of its revenue from KICO, including revenues from earned premiums, ceding commissions from quota share reinsurance, net investment income generated from its investment portfolio, and net realized gains and losses on investment securities.